ZAK Protein (Transcript Variant 2) (Myc-DYKDDDDK Tag)
-
- Antigène Voir toutes ZAK Protéines
- ZAK (Mitogen-Activated Protein Kinase Kinase Kinase MLT (ZAK))
- Type de proteíne
- Recombinant
- Attributs du protein
- Transcript Variant 2
-
Origine
- Humain
-
Source
- HEK-293 Cells
- Purification/Conjugué
- Cette ZAK protéine est marqué à la Myc-DYKDDDDK Tag.
- Application
- Antibody Production (AbP), Standard (STD)
- Attributs du produit
-
- Recombinant human MLTK (transcript variant 2) protein expressed in HEK293 cells.
- Produced with end-sequenced ORF clone
- Pureté
- > 80 % as determined by SDS-PAGE and Coomassie blue staining
- Top Product
- Discover our top product ZAK Protéine
-
-
- Indications d'application
-
Recombinant human proteins can be used for:
Native antigens for optimized antibody production
Positive controls in ELISA and other antibody assays - Commentaires
-
The tag is located at the C-terminal.
- Restrictions
- For Research Use only
-
- Concentration
- 50 μg/mL
- Buffer
- 25 mM Tris.HCl, pH 7.3, 100 mM glycine, 10 % glycerol.
- Stock
- -80 °C
- Stockage commentaire
- Store at -80°C. Thaw on ice, aliquot to individual single-use tubes, and then re-freeze immediately. Only 2-3 freeze thaw cycles are recommended.
-
- Antigène
- ZAK (Mitogen-Activated Protein Kinase Kinase Kinase MLT (ZAK))
- Autre désignation
- Mltk (ZAK Produits)
- Sujet
- This gene is a member of the MAPKKK family of signal transduction molecules and encodes a protein with an N-terminal kinase catalytic domain, followed by a leucine zipper motif and a sterile-alpha motif (SAM). This magnesium-binding protein forms homodimers and is located in the cytoplasm. The protein mediates gamma radiation signaling leading to cell cycle arrest and activity of this protein plays a role in cell cycle checkpoint regulation in cells. The protein also has pro-apoptotic activity. Alternate transcriptional splice variants, encoding different isoforms, have been characterized.
- Poids moléculaire
- 51.4 kDa
- NCBI Accession
- NP_598407
-